Author:
Shah Maulin,Mobaligh Neigena,Niku Adam,Shiota Takahiro,Siegel Robert J.,Rader Florian
Subject
Cardiology and Cardiovascular Medicine
Reference20 articles.
1. Outcomes after cardioversion and atrial fibrillation ablation in patients treated with rivaroxaban and warfarin in the ROCKET AF trial;Piccini;J. Am. Coll. Cardiol.,2013
2. Efficacy and safety of apixaban in patients after cardioversion for atrial fibrillation: insights from the ARISTOTLE trial (apixaban for reduction in stroke and other thromboembolic events in atrial fibrillation);Flaker;J. Am. Coll. Cardiol.,2014
3. Dabigatran versus warfarin in patients with atrial fibrillation: an analysis of patients undergoing cardioversion;Nagarakanti;Circulation.,2011
4. Adherence to a novel oral anticoagulant among patients with atrial fibrillation;Zhou;J Manag Care Spec Pharm.,2015
5. January CT, Wann LS, Calkins H, Field ME, Chen LY, Furie KL, et al. 2019 AHA/ACC/HRS Focused Update of the 2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Rhythm Society. Heart Rhythm. 2019.
Cited by
11 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献